• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC BOSTON SCIENTIFIC SYNERGY MR; BOSTON SCIENTIFIC SYNERGY MR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC BOSTON SCIENTIFIC SYNERGY MR; BOSTON SCIENTIFIC SYNERGY MR STENT Back to Search Results
Catalog Number 39260-2835
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Chest Pain (1776); Occlusion (1984); Thrombus (2101)
Event Date 05/17/2018
Event Type  Injury  
Event Description
On (b)(6) 2017 patient admitted through er with stemi, taken emergently to ccl where films reveal totally occluded mid rca consistent with large amount of thrombus.Overlapping inflations performed with 2.5x15 emerge providing sluggish flow.Thrombectomy performed and brisk flow returned with minimal residual defect.The 3.5x28 synergy deployed with good results.Procedure medications include asa 325 mg, heparin, and brilinta.Patient did well and was discharged (b)(6) 2017 on medications including asa 81 mg qd, and brilinta 90mg bid.On (b)(6) 2018 1000 patient has chest pain, calls ems, and takes asa and brilinta before their arrival.To er with stemi.Ccl films reveal total thrombotic occlusion of previously placed stent.H and p notes that patient had done well post op, but at office visit (b)(6) 2018 states that he has stopped asa on his own and is taking brilinta only.Unclear from chart whether patient resumed asa then, only that he took asa and brilinta that morning when he called ems.Mid rca treated with thrombectomy, and 3.5x20 nc emerge with restoration of timi iii flow.Procedure medications include heparin, and prasugrel in addition to the patient's asa and brilinta at home.Patient did well and discharged (b)(6) 2018 on medications including asa 325mg qd and prasugrel 10 mg qd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BOSTON SCIENTIFIC SYNERGY MR
Type of Device
BOSTON SCIENTIFIC SYNERGY MR STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC
MDR Report Key7564928
MDR Text Key110068049
Report NumberMW5077592
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 05/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/01/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/02/2018
Device Catalogue Number39260-2835
Device Lot Number20618609
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age87 YR
Patient Weight86
-
-